I wanted to address the Corona Virus Pandemic scare and why I'm not afraid. As you will read in this study I found at PubMed on Aronia Berry's antiviral activity, the study states that 250,000-500,000 people die world wide each year from the ordinary flu virus. You have to ask yourself why are they trying to scare us???
Just as I take dietary precautions during cold and flu season by taking Vit C, Vit D, and colloidal silver, I now add extra Aronia Berry juice to my regime. As the study states, Aronia is a valuable source for antiviral agents as influenza therapeutics.
See link on bottom for more information or click here
Clinical research findings...
Biochem Biophys Res Commun. 2013 Oct 11;440(1):14-9. doi: 10.1016/j.bbrc.2013.08.090. Epub 2013 Sep 5.
Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses.
Park S1, Kim JI, Lee I, Lee S, Hwang MW, Bae JY, Heo J, Kim D, Han SZ, Park MS.
Author information
Abstract
The influenza virus is highly contagious in human populations around the world and results in approximately 250,000-500,000 deaths annually. Vaccines and antiviral drugs are commonly used to protect susceptible individuals. However, the antigenic mismatch of vaccines and the emergence of resistant strains against the currently available antiviral drugs have generated an urgent necessity to develop a novel broad-spectrum anti-influenza agent. Here we report that Aronia melanocarpa (black chokeberry, Aronia), the fruit of a perennial shrub species that contains several polyphenolic constituents, possesses in vitro and in vivo efficacy against different subtypes of influenza viruses including an oseltamivir-resistant strain. These anti-influenza properties of Aronia were attributed to two constituents, ellagic acid and myricetin. In an in vivo therapeutic mouse model, Aronia, ellagic acid, and myricetin protected mice against lethal challenge. Based on these results, we suggest that Aronia is a valuable source for antiviral agents and that ellagic acid and myricetin have potential as influenza therapeutics.
Copyright © 2013 Elsevier Inc. All rights reserved.
|
|
|
